That's the sobering reality uncovered by a New Scientist investigation into the bioterror risks posed by the booming business of gene synthesis. Dozens of biotech firms now offer to synthesise complete genes from the chemical components of DNA (See "A dollar a base pair"). Yet some are carrying out next to no checks on what they are being asked to make, or by whom. It raises the frightening prospect of terrorists mail-ordering genes for key bioweapon agents such as smallpox, and using them to engineer new and deadly pathogens.
These loose ordering procedures are even more of a problem when combined with the recent publication of the 1918 flu virus which was critized by Ray Kurzwell and Bill Joy
The combination of loose ordering procedures and loose informational procedures is a bad combination.